Muscle Loss Is Associated with Overall Survival in Patients with Metastatic Colorectal Cancer Independent of Tumor Mutational Status and Weight Loss-Reference-Cited by-同舟云学术

Muscle Loss Is Associated with Overall Survival in Patients with Metastatic Colorectal Cancer Independent of Tumor Mutational Status and Weight Loss

Published:2021-05-06 Issue:6 Volume:26 Page:
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:The Oncol

Author:

Best Till Dominik¹²^ORCID,Roeland Eric J.³^ORCID,Horick Nora K.⁴^ORCID,Van Seventer Emily E.³^ORCID,El‐Jawahri Areej³^ORCID,Troschel Amelie S.²^ORCID,Johnson Patrick C.³,Kanter Katie N.³^ORCID,Fish Madeleine G.³^ORCID,Marquardt J. Peter²⁵^ORCID,Bridge Christopher P.⁶^ORCID,Temel Jennifer S.³^ORCID,Corcoran Ryan B.³^ORCID,Nipp Ryan D.³^ORCID,Fintelmann Florian J.²^ORCID

Affiliation:

1. Department of Radiology, Charité ‐ Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health Berlin Germany

2. Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital & Harvard Medical School Boston Massachusetts

3. Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School Boston Massachusetts USA

4. Department of Statistics, Massachusetts General Hospital & Harvard Medical School Boston Massachusetts USA

5. School of Medicine, RWTH Aachen University Aachen Germany

6. MGH and BWH Center for Clinical Data Science Boston Massachusetts USA

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/onco.13774

Reference38 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer